Skip to main content
Equibles

Squarepoint Ops LLC

Position in MGNX — Macrogenics Inc

CIK 1642575 NEW YORK, NY
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$542,286
+$10,969 QoQ
Shares Held
117,378
-36.2% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 122 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. MGNX ranks #141 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in MGNX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $542,286 117,378
2026-03-31 $531,317 183,847
2025-12-31 $503,002 312,424
2025-09-30 $647,863 385,633
2025-06-30 $67,134 55,483
2025-03-31 $13,317 10,486
2024-09-30 $122,289 37,170
2023-09-30 $348,605 74,808
2023-06-30 $559,037 104,493
2023-03-31 $543,335 75,779
2022-12-31 $164,717 24,548
2022-09-30 $240,722 69,573
2022-06-30 $449,181 152,265
2022-03-31 $160,914 18,265
2021-12-31 $523,005 32,586
2021-03-31 $2,420,536 75,998
2020-12-31 $1,193,177 52,195
2020-09-30 $465,989 18,499
2020-06-30 $1,803,576 64,598
2020-03-31 $313,319 53,835